Previous issue | Volume 84 | ESPE2015 | Next issue

54th Annual ESPE

Barcelona, Spain
01 Oct 2015 - 03 Oct 2015

Card image cap
Barcelona, Spain; 1-3 October 2015 Further information

Poster Presentations Poster Category 1

Growth Hormone

Influence of Genetic Variation on the Response to Recombinant Human Growth Hormone Treatment in Children with GH Deficiency: An Analysis of 13 Single Nucleotide Polymorphisms and the GH Receptor Exon 3 Deletion
aDepartment of Pediatrics and Adolescent Medicine, Division of Pediatric Endocrinology, Saarland University Medical Center, Homburg, Germany; bInstitute of Human Genetics, University Hospital Magdeburg, Magdeburg, Germany
The Growth Response to Growth Hormone Treatment is Greater in Patients with SHOX Enhancer Deletions Compared to SHOX Defects
aLeiden University Medical Center, Leiden, The Netherlands; bDutch Growth Research Foundation, Rotterdam, The Netherlands; cUniversity Medical Center Groningen, Groningen, The Netherlands; dVU University Medical Center, Amsterdam, The Netherlands; eErasmus Medical Center, Rotterdam, The Netherlands
Assessment of Primary Cancers in Growth Hormone-Treated Paediatric Patients Compared with General Population Registries: An Epidemiological Analysis of a Large, Multinational, Prospective Observational Study
aEli Lilly and Company, Windlesham, UK; bEli Lilly and Company, Indianapolis, IN, USA; cSt Jude Children’s Research Hospital, Memphis, TN, USA; dUniversitäts-Kinderklinik, University of Münster, Münster, Germany; eUniversity of Giessen, University Children’s Hospital, Giessen, Germany
Genetic Markers Contribute to the PREDICTION of Response to GH in Severe but not Mild GH Deficiency
aFaculty of Medical and Human Sciences, Institute of Human Development, University of Manchester and Manchester Academic Health Science Centre, Royal Manchester Children’s Hospital, Manchester, UK; bQuartz Bio, Geneva, Switzerland; cGenizon BioSciences, St Laurent, Quebec, Canada; dMerck Serono, Darmstadt, Germany; eDepartment Pediatrie, Hôpital Mère-Enfant – Université Claude Bernard, Lyon, France
Effects of Growth Hormone Treatment on Immunity
aUnidad de Endocrinología Pediátrica, HURS, Córdoba, Spain; bGrupo Paidi CTS-329 (IMIBIC), Córdoba, Spain; cServicio de Inmunología, HURS, Córdoba, Spain
The Growth Hormone Treatment Results in the Increase of Irisin Concentration in Plasma
aDepartment of Endocrinology and Diabetology for Children and Adolescents, Wroclaw Medical University, Wroclaw, Poland; bDepartment of Endocrinology, Diabetes and Isotope Therapy, Wroclaw Medical University, Wroclaw, Poland
A Novel OTX2 Gene Mutation in a Child with Growth Hormone Deficiency
aPediatric Sections, Department of Biomedical Sciences and Human Oncology, University of Bari ‘Aldo Moro’, Bari, Italy; bMedical Genetics Unit, Department of Laboratory Medicine, Niguarda Ca’ Granda Hospital, Milan, Italy; cDepartment of Surgery and Translational Medicine, Eye Clinic, University of Florence, Florence, Italy
The Dose Dependent Effect of Growth Hormone Therapy in Patients with IGF1 Receptor Haploinsufficiency due to Heterozygous Deletion
Department of Pediatrics and Neonatology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan